These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 19841449)
41. Prevalence and incidence of HPV genital infection in women. Velicer C; Zhu X; Vuocolo S; Liaw KL; Saah A Sex Transm Dis; 2009 Nov; 36(11):696-703. PubMed ID: 19652630 [TBL] [Abstract][Full Text] [Related]
42. A cost-utility analysis of adding a bivalent or quadrivalent HPV vaccine to the Irish cervical screening programme. Dee A; Howell F Eur J Public Health; 2010 Apr; 20(2):213-9. PubMed ID: 19864366 [TBL] [Abstract][Full Text] [Related]
43. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine. Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114 [TBL] [Abstract][Full Text] [Related]
45. Correlating immunity with protection for HPV infection. Frazer I Int J Infect Dis; 2007 Nov; 11 Suppl 2():S10-6. PubMed ID: 18162240 [TBL] [Abstract][Full Text] [Related]
46. Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States. Grant LA; Dunne EF; Chesson H; Markowitz LE Vaccine; 2011 Mar; 29(13):2365-70. PubMed ID: 21277406 [TBL] [Abstract][Full Text] [Related]
47. ACP Journal Club. Quadrivalent HPV vaccine reduced risk for HPV infection and related disease in women 24 to 45 years of age. Granwehr BP Ann Intern Med; 2009 Oct; 151(8):JC4-12. PubMed ID: 19841449 [No Abstract] [Full Text] [Related]
48. Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine. Villa LL Int J Infect Dis; 2007 Nov; 11 Suppl 2():S17-25. PubMed ID: 18162241 [TBL] [Abstract][Full Text] [Related]
49. Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics. Pomfret TC; Gagnon JM; Gilchrist AT J Clin Pharm Ther; 2011 Feb; 36(1):1-9. PubMed ID: 21198715 [TBL] [Abstract][Full Text] [Related]
50. Protecting our patients from HPV and HPV-related diseases: the role of vaccines. Mahoney MC J Fam Pract; 2006 Nov; Suppl():10-7. PubMed ID: 17366753 [TBL] [Abstract][Full Text] [Related]
51. The prophylactic role for the human papillomavirus quadrivalent vaccine in males. Yancey AM; Pitlick JM; Forinash AB Ann Pharmacother; 2010; 44(7-8):1314-8. PubMed ID: 20501891 [TBL] [Abstract][Full Text] [Related]